Does an Asthma Control Test score of 13 in an adult with asthma indicate severe persistent asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

An ACT Score of 13 Does NOT Indicate Severe Persistent Asthma—It Indicates Very Poorly Controlled Asthma

An Asthma Control Test (ACT) score of 13 indicates very poorly controlled asthma, not severe persistent asthma. These are fundamentally different concepts that must not be confused in clinical practice.

Understanding the Critical Distinction

Asthma Severity vs. Asthma Control

The NAEPP EPR-3 guidelines clearly distinguish between two separate assessment frameworks 1, 2:

  • Asthma severity is classified as intermittent, mild persistent, moderate persistent, or severe persistent. This classification is ideally determined before initiating therapy and reflects the intrinsic intensity of the disease process 2.

  • Asthma control measures how well current symptoms and risks are minimized by treatment. It is assessed after therapy is initiated and guides ongoing management decisions 1, 2.

Your patient's ACT score of 13 tells you nothing about their asthma severity—it only tells you their current control status is very poor.

What an ACT Score of 13 Actually Means

According to validated guidelines 1:

  • ACT ≤ 15: Very poorly controlled asthma
  • ACT 16-19: Not well controlled asthma
  • ACT ≥ 20: Well controlled asthma

With a score of 13, this patient falls squarely into the "very poorly controlled" category. Research confirms that an ACT score ≤19 has 94% sensitivity for identifying uncontrolled asthma 3, and scores this low are associated with significantly increased risk of exacerbations and urgent healthcare utilization 3, 4.

Immediate Clinical Implications

This patient requires urgent therapeutic escalation regardless of their underlying severity classification 1. According to the stepwise management approach:

Recommended Actions:

  1. Consider a short course of oral systemic corticosteroids (40-60 mg daily for 5-10 days in adults) 5

  2. Step up therapy by 1-2 steps based on current treatment regimen 1

  3. Reassess in 2 weeks to evaluate response 1

  4. Before stepping up, verify:

    • Medication adherence (a major cause of poor control) 6
    • Proper inhaler technique 6
    • Environmental trigger exposures 6
    • Comorbid conditions (rhinitis, GERD, obesity, OSA) 2, 6

Determining Actual Severity

To classify this patient's true asthma severity, you need to know what level of treatment is required to achieve and maintain control 2. Severe persistent asthma is defined by requiring:

  • Step 5 or 6 care: High-dose ICS plus LABA, possibly with additional controllers (leukotriene modifiers, theophylline) or biologics (omalizumab for allergic asthma) 2, 1

OR

  • Continuous or near-continuous oral corticosteroids (>50% of the year) to maintain control 7

A patient could have mild persistent asthma (requiring only Step 2 care) but still have an ACT score of 13 if they're non-adherent, using improper technique, or exposed to uncontrolled triggers.

Common Clinical Pitfall

The most dangerous error is assuming poor control automatically means severe disease and immediately escalating to high-intensity therapy without first addressing:

  • Adherence issues: 40-50% of patients underuse prescribed medications 6
  • Technique problems: Even with prescriptions, improper inhaler use prevents benefit 6
  • Trigger exposures: Ongoing allergen, occupational, or irritant exposures 6
  • Comorbidities: Untreated rhinitis, GERD, or OSA significantly impair control 2, 6

The Bottom Line

An ACT score of 13 is a red flag for very poor asthma control requiring immediate intervention, but it provides zero information about underlying disease severity. Severity can only be determined by observing what level of treatment ultimately achieves sustained control 2. Step up therapy now, address modifiable factors, and reassess—the patient's response to optimized treatment will reveal their true severity classification.

Related Questions

What is the appropriate GINA-recommended treatment for a 13-year-old with asthma who experiences symptoms twice per week?
What is the appropriate evaluation and treatment for a 15-year-old male with exercise‑induced dyspnea suggestive of asthma?
What is the appropriate management of a 17-year-old with an acute asthma exacerbation and fever?
In a 17-year-old with an asthma exacerbation, which long‑acting medication should be initiated?
In a 10-year-old child with asthma who is experiencing an acute exacerbation that has progressed to moderate persistent asthma, what are the recommendations for initiating controller therapy?
Is a 24‑hour urine normetanephrine level of 5.30 µmol diagnostic for pheochromocytoma?
What tests should be performed next in a patient with a low estimated glomerular filtration rate and elevated glucose?
What is the recommended management for lumbar spinal stenosis with neurogenic claudication that improves when sitting and worsens with standing?
What are the clinical implications of an intra‑atrial right‑to‑left shunt?
What does chronically low alkaline phosphatase on laboratory testing indicate?
In a 63‑year‑old woman with long‑standing rheumatoid arthritis, high anti‑cyclic citrullinated peptide antibodies, normal rheumatoid factor, hypertension, currently taking methotrexate and hydroxychloroquine, who is intolerant to sulfasalazine and leflunomide and has persistent disease activity with elevated C‑reactive protein and anemia (hemoglobin 8.5 g/dL), what is the most effective disease‑modifying antirheumatic drug to add?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.